Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 485

1.

Fifty years of ERA-EDTA Registry-a registry in transition.

Jager KJ, Wanner C.

Kidney Int Suppl (2011). 2015 Jun;5(1):12-14.

2.

Correction: Heart Failure in a Cohort of Patients with Chronic Kidney Disease: The GCKD Study.

Beck H, Titze SI, Hübner S, Busch M, Schlieper G, Schultheiss UT, Wanner C, Kronenberg F, Krane V, Eckardt KU, Köttgen A; GCKD Investigators.

PLoS One. 2015 Jun 15;10(6):e0131034. doi: 10.1371/journal.pone.0131034. eCollection 2015.

3.

Renal replacement therapy in Europe: a summary of the 2012 ERA-EDTA Registry Annual Report.

Pippias M, Stel VS, Abad Diez JM, Afentakis N, Herrero-Calvo JA, Arias M, Tomilina N, Bouzas Caamaño E, Buturovic-Ponikvar J, Čala S, Caskey FJ, Castro de la Nuez P, Cernevskis H, Collart F, Alonso de la Torre R, García Bazaga Mde L, De Meester J, Díaz JM, Djukanovic L, Ferrer Alamar M, Finne P, Garneata L, Golan E, González Fernández R, Gutiérrez Avila G, Heaf J, Hoitsma A, Kantaria N, Kolesnyk M, Kramar R, Kramer A, Lassalle M, Leivestad T, Lopot F, Macário F, Magaz A, Martín-Escobar E, Metcalfe W, Noordzij M, Palsson R, Pechter Ü, Prütz KG, Ratkovic M, Resić H, Rutkowski B, Santiuste de Pablos C, Spustová V, Süleymanlar G, Van Stralen K, Thereska N, Wanner C, Jager KJ.

Clin Kidney J. 2015 Jun;8(3):248-61. doi: 10.1093/ckj/sfv014. Epub 2015 Mar 23.

4.

Effect of High-Flux Dialysis on Circulating FGF-23 Levels in End-Stage Renal Disease Patients: Results from a Randomized Trial.

Schneider A, Schneider MP, Krieter DH, Genser B, Scharnagl H, Stojakovic T, Wanner C, Drechsler C.

PLoS One. 2015 May 29;10(5):e0128079. doi: 10.1371/journal.pone.0128079. eCollection 2015.

5.

Intestinal cholesterol absorption, treatment with atorvastatin, and cardiovascular risk in hemodialysis patients.

Silbernagel G, Fauler G, Genser B, Drechsler C, Krane V, Scharnagl H, Grammer TB, Baumgartner I, Ritz E, Wanner C, März W.

J Am Coll Cardiol. 2015 Jun 2;65(21):2291-8. doi: 10.1016/j.jacc.2015.03.551.

PMID:
26022817
6.

Fabry disease and the heart.

Seydelmann N, Wanner C, Störk S, Ertl G, Weidemann F.

Best Pract Res Clin Endocrinol Metab. 2015 Mar;29(2):195-204. doi: 10.1016/j.beem.2014.10.003. Epub 2014 Oct 16. Review.

7.

Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association Registry.

Hruskova Z, Stel VS, Jayne D, Aasarød K, De Meester J, Ekstrand A, Eller K, Heaf JG, Hoitsma A, Martos Jimenéz C, Ravani P, Wanner C, Tesar V, Jager KJ.

Am J Kidney Dis. 2015 May 12. pii: S0272-6386(15)00606-X. doi: 10.1053/j.ajkd.2015.03.025. [Epub ahead of print]

PMID:
25975963
8.

Kidney Disease End Points in a Pooled Analysis of Individual Patient-Level Data From a Large Clinical Trials Program of the Dipeptidyl Peptidase 4 Inhibitor Linagliptin in Type 2 Diabetes.

Cooper ME, Perkovic V, McGill JB, Groop PH, Wanner C, Rosenstock J, Hehnke U, Woerle HJ, von Eynatten M.

Am J Kidney Dis. 2015 May 7. pii: S0272-6386(15)00604-6. doi: 10.1053/j.ajkd.2015.03.024. [Epub ahead of print]

9.

Pharmacokinetics of Certoparin During In Vitro and In Vivo Dialysis.

Krieter DH, Fink S, Dorsch O, Harenberg J, Melzer N, Wanner C, Lemke HD.

Artif Organs. 2015 Apr 20. doi: 10.1111/aor.12475. [Epub ahead of print]

PMID:
25900127
10.

Hepcidin-25 in diabetic chronic kidney disease is predictive for mortality and progression to end stage renal disease.

Wagner M, Ashby DR, Kurtz C, Alam A, Busbridge M, Raff U, Zimmermann J, Heuschmann PU, Wanner C, Schramm L.

PLoS One. 2015 Apr 20;10(4):e0123072. doi: 10.1371/journal.pone.0123072. eCollection 2015.

11.

Calculating the Rate of Senescence From Mortality Data: An Analysis of Data From the ERA-EDTA Registry.

Koopman JJ, Rozing MP, Kramer A, Abad JM, Finne P, Heaf JG, Hoitsma AJ, De Meester JM, Palsson R, Postorino M, Ravani P, Wanner C, Jager KJ, van Bodegom D, Westendorp RG.

J Gerontol A Biol Sci Med Sci. 2015 Apr 16. pii: glv042. [Epub ahead of print]

PMID:
25887122
12.

Heart failure in a cohort of patients with chronic kidney disease: the GCKD study.

Beck H, Titze SI, Hübner S, Busch M, Schlieper G, Schultheiss UT, Wanner C, Kronenberg F, Krane V, Eckardt KU, Köttgen A; GCKD Investigators.

PLoS One. 2015 Apr 13;10(4):e0122552. doi: 10.1371/journal.pone.0122552. eCollection 2015.

13.

Subclinical Hypothyroidism and the Risk of Stroke Events and Fatal Stroke: An Individual Participant Data Analysis.

Chaker L, Baumgartner C, den Elzen WP, Ikram MA, Blum MR, Collet TH, Bakker SJ, Dehghan A, Drechsler C, Luben RN, Hofman A, Portegies ML, Medici M, Iervasi G, Stott DJ, Ford I, Bremner A, Wanner C, Ferrucci L, Newman AB, Dullaart RP, Sgarbi JA, Ceresini G, Maciel RM, Westendorp RG, Jukema JW, Imaizumi M, Franklyn JA, Bauer DC, Walsh JP, Razvi S, Khaw KT, Cappola AR, Völzke H, Franco OH, Gussekloo J, Rodondi N, Peeters RP; Thyroid Studies Collaboration.

J Clin Endocrinol Metab. 2015 Jun;100(6):2181-91. doi: 10.1210/jc.2015-1438. Epub 2015 Apr 9.

PMID:
25856213
14.

Renal replacement therapy in Europe: a summary of the 2011 ERA-EDTA Registry Annual Report.

Noordzij M, Kramer A, Abad Diez JM, Alonso de la Torre R, Arcos Fuster E, Bikbov BT, Bonthuis M, Bouzas Caamaño E, Čala S, Caskey FJ, Castro de la Nuez P, Cernevskis H, Collart F, Díaz Tejeiro R, Djukanovic L, Ferrer-Alamar M, Finne P, García Bazaga Mde L, Garneata L, Golan E, Gonzalez Fernández R, Heaf JG, Hoitsma A, Ioannidis GA, Kolesnyk M, Kramar R, Lasalle M, Leivestad T, Lopot F, van de Luijtgaarden MW, Macário F, Magaz Á, Martín Escobar E, de Meester J, Metcalfe W, Ots-Rosenberg M, Palsson R, Piñera C, Pippias M, Prütz KG, Ratkovic M, Resić H, Rodríguez Hernández A, Rutkowski B, Spustová V, Stel VS, Stojceva-Taneva O, Süleymanlar G, Wanner C, Jager KJ.

Clin Kidney J. 2014 Apr;7(2):227-38. doi: 10.1093/ckj/sfu007. Epub 2014 Mar 2.

15.

Secreted frizzled-related protein 4 predicts progression of autosomal dominant polycystic kidney disease.

Zschiedrich S, Budde K, Nürnberger J, Wanner C, Sommerer C, Kunzendorf U, Banas B, Hoerl WH, Obermüller N, Arns W, Pavenstädt H, Gaedeke J, Lindner TH, Faerber L, Wimmer P, Stork R, Eckardt KU, Walz G.

Nephrol Dial Transplant. 2015 Apr 1. pii: gfv077. [Epub ahead of print]

PMID:
25832108
16.

Optimization of the convection volume in online post-dilution haemodiafiltration: practical and technical issues.

Chapdelaine I, de Roij van Zuijdewijn CL, Mostovaya IM, Lévesque R, Davenport A, Blankestijn PJ, Wanner C, Nubé MJ, Grooteman MP; EUDIAL Group, Blankestijn PJ, Davenport A, Basile C, Locatelli F, Maduell F, Mitra S, Ronco C, Shroff R, Tattersall J, Wanner C.

Clin Kidney J. 2015 Apr;8(2):191-8. doi: 10.1093/ckj/sfv003. Epub 2015 Feb 16.

17.

Chronic kidney disease: Statins in chronic kidney disease: time to move on?

Haynes R, Wanner C.

Nat Rev Nephrol. 2015 May;11(5):262-3. doi: 10.1038/nrneph.2015.36. Epub 2015 Mar 24.

PMID:
25802077
18.

Moderator's view: Treatment of vascular calcification is a physical impossibility, so far.

Wanner C.

Nephrol Dial Transplant. 2015 Mar;30(3):358-9. doi: 10.1093/ndt/gfv019. No abstract available.

PMID:
25712938
19.

Homoarginine and Clinical Outcomes in Renal Transplant Recipients: Results From the Assessment of Lescol in Renal Transplantation Study.

Drechsler C, Pihlstrøm H, Meinitzer A, Pilz S, Tomaschitz A, Abedini S, Fellstrom B, Jardine AG, Wanner C, März W, Holdaas H.

Transplantation. 2015 Feb 11. [Epub ahead of print]

PMID:
25675199
20.

Protein carbamylation is associated with heart failure and mortality in diabetic patients with end-stage renal disease.

Drechsler C, Kalim S, Wenger JB, Suntharalingam P, Hod T, Thadhani RI, Karumanchi SA, Wanner C, Berg AH.

Kidney Int. 2015 Jun;87(6):1201-8. doi: 10.1038/ki.2014.429. Epub 2015 Feb 11.

PMID:
25671766
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk